HAM24 HL Tabs
Unveiling The Honorary Lectures at this year’s EFORT congress.
From Innovation to Impact: enhancing patient outcomes through evidence-based practices and new technologies.
The much-anticipated EFORT Annual Congress in Hamburg, themed "Collaborating for Success," is proud to present the two distinguished Honorary Lecturers who promise to fuel discussions around the future of orthopaedic surgery.
For the Erwin Morscher Honorary Lecture guest speaker Matthew Costa will delve into:
“Measuring Clinical Effectiveness in Trauma and Orthopaedic Surgery:
Which Questions and How to Answer Them”
A timely topic, as clinical effectiveness is evaluated through rigorous assessment methods such as safety, efficacy, patient satisfaction, and cost-effectiveness.
Meanwhile Michael Freeman Honorary Lecturer Nicolaas C. Budhiparama, a trailblazer in the field, hails from the Asia Pacific Orthopaedic Association (APOA), the guest nation at this year's event. Budhiparama is set to redefine the landscape of knee arthroplasty surgery. We are honored that he is lending his expertise to the Michael Freeman Honorary Lecture with his presentation titled:
“The Future of Knee Arthroplasty Surgery is Here: How Asia Pacific is Embracing New Technologies”
So, where do these lectures find their commonalities?
In the dynamic landscape of healthcare, the journey from embracing new technologies and adopting evidence-based approaches to measuring clinical effectiveness culminates in one paramount goal: improving patient outcomes. Seen as a journey, the two sessions represent a continuum of innovation, collaboration, and dedication to enhancing the quality of care provided to patients.
Both lectures are future oriented and innovative. They touch upon the future direction of orthopaedic surgery. The discussion of new technologies in knee arthroplasty surgery and the need to answer questions about clinical effectiveness, both highlight the importance of innovation in advancing orthopaedic practices, two themes which have always found a home within EFORT’s educational initiatives.
What will you learn?
By focusing on both aspects, surgeons gain valuable insights into how emerging technologies can be harnessed to achieve tangible improvements in clinical outcomes. This holistic approach not only enriches the congress programme by showcasing the latest advancements in surgical techniques and technologies but also equips the attendee with the knowledge and tools needed to evaluate and optimize their clinical practices effectively. Together, these topics create a compelling narrative that underscores the congress's commitment to excellence, innovation, and the continuous advancement of surgical care.
Thursday 23 May 2024 | 12:15 – 12:45 | Auditorium: Hamburg
Measuring Clinical Effectiveness in Trauma and Orthopaedic Surgery: Which Questions and How to Answer Them
By Prof. Matthew Costa | Professor of Orthopaedic Trauma, University of Oxford, United Kingdom
Matthew Costa is Professor of orthopaedic trauma surgery.
Prof. Costa was appointed Professor of Orthopaedic Trauma, University of Oxford, UK, in 2015. He was previously Professor of Trauma and Orthopaedics at University of Warwick. Prof. Costa is also Honorary Consultant Trauma Surgeon at the John Radcliffe Hospital, Oxford, UK.
Prof. Costa's research interest is in clinical and cost effectiveness of musculoskeletal interventions and he is Chief Investigator for a series of randomised trials and associated studies supported by grants from the UK National Institute of Health Research. His work has been cited widely, and informs many guidelines from the National Institute for Health and Care Excellence (NICE).
In an interview about making trauma research more patient-focused, when asked about the desired outcome for his work, he stated, "Reducing this loss of quality of life, and that means moving trauma up the research agenda". There are some areas where we don’t even know what the best treatments are. This is quite depressing but also quite exciting because there’s so much opportunity to do better.
Latest Prof. Costa Research Papers
High-dose dual-antibiotic loaded cement for hip hemiarthroplasty in the UK (WHiTE 8): a randomised controlled trial.
Agni NR, Costa ML, Achten J, Peckham N, Dutton SJ, Png ME, Reed MR; WHiTE 8 Investigators
Lancet. 2023 Jun 21:S0140-6736(23)00962-5
Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture.
Fernandez MA, Achten J, Parsons N, Griffin XL, Png ME, Gould J, McGibbon A, Costa ML; WHiTE 5 Investigators.
N Engl J Med. 2022 Feb 10;386(6):521-530.
Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial.
Costa ML, Achten J, Ooms A, Png ME, Cook JA, Lamb SE, Hedley H, Dias J; DRAFFT2 Collaborators.
BMJ. 2022 Jan 19;376:e068041
Plaster cast versus functional brace for non-surgical treatment of Achilles tendon rupture (UKSTAR): a multicentre randomised controlled trial and economic evaluation.
Costa ML, Achten J, Marian IR, Dutton SJ, Lamb SE, Ollivere B, Maredza M, Petrou S, Kearney RS; UKSTAR trial collaborators.
Lancet. 2020 Feb 8;395(10222):441-448
Friday 24 May 2024 | 12:15 – 12:45 | Auditorium: Hamburg
The Future of Knee Arthroplasty Surgery is Here: How Asia Pacific is Embracing New Technologies
By Prof. Nicolaas C. Budhiparama, MD, PhD (LUMC, NL), PhD (UGM, ID), FICS
Prof. Nicolaas C. Budhiparama, is an Indonesian Orthopaedic and Traumatology specialist who obtained his specialist degree at Leiden University Medical Center LUMC in the Netherlands.
Serving as the second Vice-President of APOA (Asia Pacific Orthopaedic Association) from 2022 to 2024, he is a prominent figure in the field. Dr. Budhiparama is also the founder of the Nicolaas Institute of Constructive Orthopaedic Research & Education Foundation for Arthroplasty & Sports Medicine.
Recognized for his exceptional contributions, he was honored with the Habibie Prize 2021 for his achievements in Medicine and Biotechnology. Additionally, his philanthropic endeavors and academic commitments led to his appointment as an "Honorary Professor" at the Faculty of Medicine at Universitas Airlangga, Surabaya, Indonesia, in 2022. In the same year, he spearheaded the International Collaboration between Leiden University Medical Center LUMC, the Netherlands, and Universitas Airlangga, Indonesia.
Dr. Budhiparama envisions the Asia Pacific region as a future hub for arthroplasty training, highlighting the unique and challenging cases that contribute to the region's significance in orthopaedic surgery.